RGC (Regencell Bioscience Holdings) Market Cap : $71.83 Mil (As of Dec. 11, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Regencell Bioscience Holdings's share price for the quarter that ended in Jun. 2024 was $3.36. Regencell Bioscience Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 13.01 Mil. Therefore, Regencell Bioscience Holdings's market cap for the quarter that ended in Jun. 2024 was $43.72 Mil.

Regencell Bioscience Holdings's quarterly market cap declined from Jun. 2023 ($299.82 Mil) to Dec. 2023 ($136.64 Mil) and declined from Dec. 2023 ($136.64 Mil) to Jun. 2024 ($43.72 Mil).

Regencell Bioscience Holdings's annual market cap declined from Jun. 2022 ($450.31 Mil) to Jun. 2023 ($299.82 Mil) and declined from Jun. 2023 ($299.82 Mil) to Jun. 2024 ($43.72 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Regencell Bioscience Holdings's Enterprise Value for Today is $68.38 Mil.

Regencell Bioscience Holdings Market Cap Historical Data

The historical data trend for Regencell Bioscience Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Market Cap Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Market Cap

Get a 7-Day Free Trial

450.31

299.82

43.72

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Market Cap	Get a 7-Day Free Trial						450.31	362.93	299.82	136.64	43.72

Competitive Comparison of Regencell Bioscience Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Market Cap falls into.

Regencell Bioscience Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Regencell Bioscience Holdings's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )	=	Share Price (A: Jun. 2024 )	*	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	$3.36	*	13.0129
	=	$43.72

Regencell Bioscience Holdings's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )	=	Share Price (Q: Jun. 2024 )	*	Shares Outstanding (EOP) (Q: Jun. 2024 )
	=	$3.36	*	13.0129
	=	$43.72

Regencell Bioscience Holdings (NAS:RGC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Regencell Bioscience Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.